Skip to main content
. 2024 Mar 7;13(3):611–624. doi: 10.1007/s40120-024-00591-z

Fig. 2.

Fig. 2

Mean change in monthly migraine days/monthly headache days (MMD/MHD) (a), monthly analgesic medications (b), Numerical Rating Scale (NRS) score (c), Headache Impact Test-6 (HIT-6) score (d), and Migraine Disability Assessment Scale (MIDAS) score (e) from baseline to week 48 in patients affected by high-frequency episodic migraine (HFEM, n = 49) or chronic migraine (CM, n = 81)